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Abstract
When Drosophila melanogaster embryos initiate zygotic transcription around mitotic cycle 10, the dose-sensitive expression
of specialized genes on the X chromosome triggers a sex-determination cascade that, among other things, compensates for
differences in sex chromosome dose by hypertranscribing the single X chromosome in males. However, there is an
approximately 1 hour delay between the onset of zygotic transcription and the establishment of canonical dosage
compensation near the end of mitotic cycle 14. During this time, zygotic transcription drives segmentation, cellularization,
and other important developmental events. Since many of the genes involved in these processes are on the X chromosome,
we wondered whether they are transcribed at higher levels in females and whether this might lead to sex-specific early
embryonic patterning. To investigate this possibility, we developed methods to precisely stage, sex, and characterize the
transcriptomes of individual embryos. We measured genome-wide mRNA abundance in male and female embryos at eight
timepoints, spanning mitotic cycle 10 through late cycle 14, using polymorphisms between parental lines to distinguish
maternal and zygotic transcription. We found limited sex-specific zygotic transcription, with a weak tendency for genes on
the X to be expressed at higher levels in females. However, transcripts derived from the single X chromosome in males were
more abundant that those derived from either X chromosome in females, demonstrating that there is widespread dosage
compensation prior to the activation of the canonical MSL-mediated dosage compensation system. Crucially, this new
system of early zygotic dosage compensation results in nearly identical transcript levels for key X-linked developmental
regulators, including giant (gt), brinker (brk), buttonhead (btd), and short gastrulation (sog), in male and female embryos.
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Introduction
The earliest stages of animal development are under maternal
control until mRNAs deposited prior to fertilization degrade and
zygotic transcription is initiated during a period known as the
maternal to zygotic transition (MZT). In Drosophila melanogster, the
MZT occurs amidst the 14 rapid and synchronous mitotic
divisions that mark the first several hours of development, with
zygotic transcripts appearing as early as mitotic cycle 8 [1]. By
cycle 14, when cellularization of the previously syncytial
blastoderm occurs, most processes are under the control of zygotic
transcripts.
As zygotic transcription begins, the different numbers of X
chromosomes (two in females, one in males) results in different
transcript levels for a small number of genes on the X chromosome
(the X chromosome signal elements, or XSEs), which lead to
female-specific expression of the master sex control gene Sex lethal
(Sxl) [2–4]. The low levels of SXL in males lead to the male-
specific formation of a dosage compensation complex composed of
five proteins (MSL-1, MSL-2, MSL-3, MOF, MLE) and two non-
coding RNAs (rox1 and rox2) that bind to the X chromosome,
hyperacetylate histone H4K16, and induce hypertranscription of
the male X chromosome [5–8].
However, there is a lag between the onset of zygotic
transcription and the establishment of MSL-mediated dosage
compensation: the complex is not localized on DNA, and H4K16
acetylation is not detectable, until after the blastoderm stage
[9,10], 60 to 90 min after the onset of zygotic transcription.
During this gap, zygotic transcription drives a host of important
developmental processes, including segmentation along the
anterior-posterior axis, the establishment of tissue layers along
the dorsal-ventral axis, and cellularization. These events often
require the precise spatial localization and concentration of
transcription factors and other proteins. It is therefore interesting
PLoS Biology | www.plosbiology.org 1 February 2011 | Volume 9 | Issue 2 | e1000590that many important blastoderm regulators are on the X
chromosome, and thus present in varying dosage in males and
females, including the A–P factors giant (gt), buttonhead (btd),
orthodenticle (otd) and runt (run), D–V factors brinker (brk), short
gastrulation (sog) and neijire (nej), and the cellularization factor nullo.
We were intrigued by the possibility that the absence of MSL-
mediated dosage compensation during the MZT might lead to
higher levels of mRNAs derived from genes on the X chromosome
in females, and sex-specific differences in patterning or cellular-
ization that have not been detected because systematic studies of
early developmental transcription have never differentiated male
and female embryos.
A variety of approaches have been used to profile zygotic
transcription during the MZT, including genome-wide expression
profiling with microarrays [11–15] and in situ hybridization [16].
However the genomic studies pooled mixed-sex embryos based
only on developmental time, and generally have not had sufficient
temporal resolution to distinguish events during the rapid mitotic
cycles of early development. Embryos produced to lack entire
chromosomes or chromosome arms have been used to distinguish
maternal and zygotic transcription [12], but the effects of these
significant aberrations are unknown. Imaging studies have
intrinsically higher temporal resolution, and have used differences
in RNA localization to begin to unravel the maternal and zygotic
contributions to mRNA pools. But doing such experiments on a
genomic scale requires considerable time and resources, and
current imaging projects do not distinguish male and female
embryos.
To address these limitations, we developed methods to
characterize, by sequencing, the mRNA content of individual D.
melanogaster embryos, which we combined with methods to
precisely stage and sex single embryos to generate sex-specific
time courses of maternal and zygotic transcript abundance
spanning the first wave of early zygotic transcription through the
MZT to the end of the blastoderm stage when MSL-mediated
dosage compensation is thought to begin [9,10].
Results
In order to create a precise time series of zygotic transcription in
male and female embryos during embryonic development, we
needed methods to demarcate small differences in developmental
time, to determine the sex of embryos, and to measure the entire
pool of transcripts in these embryos in a way that distinguished
mRNAs of maternal and zygotic origin.
Creating a High-Resolution Time Course
We chose to focus on the period of development bounded by
cycle 10 (when early zygotic transcription is detectable) and the
completion of cellularization in mitotic cycle 14 (when widespread
zygotic transcription has been established, right before MSL-
mediated dosage compensation is thought to begin).
To determine developmental stage, we took advantage of two
characteristics of early embryos: the tightly controlled synchronous
mitotic cycles and the process of cellularization as the embryo
transitions from a syncytium to a cellular blastoderm (Figure 1).
We examined live embryos from a maternal line carrying an RFP-
labeled histone under a fluorescent microscope and used a
combination of direct observation of mitotic cycles and quantifi-
cation of nuclear density to select embryos during interphases of
mitotic cycles 10, 11, 12, 13, and 14. Stage assignments were based
on examination of the entire embryo to avoid cases where different
portions were in different mitotic cycles [17]. We further refined
the staging within cycle 14 by examining embryos under a light
microscope and quantifying the extent of membrane invagination
during cellularization, assigning embryos to stages 14A (0%–25%
invagination), 14B (25%–50%), 14C (50%–75%), and 14D (75%–
100%). Selected embryos were immediately immersed in TRIzol,
ruptured, and frozen for subsequent extraction.
We selected at least four embryos each for cycles 10, 11, 12, 13,
14A, 14B, 14C, and 14D, and extracted DNA and RNA from
each embryo independently. We carried out whole-genome
amplification on the DNA from each embryo and genotyped it
for Y chromosomal markers to determine the sex of the embryo,
and selected at least one male and female embryo from every stage
for transcriptome analysis. Figure 1 shows the embryos we selected
immediately before DNA and RNA were extracted.
Characterizing the Transcriptomes of Single Embryos by
RNA-Seq
We obtained 75 to 100 ng of total RNA from each embryo. As
this was less starting material than required for standard mRNA
sequencing protocols, we modified the Illumina mRNA-Seq
protocol to obtain reliable data from such small quantities of
input mRNA without amplification by performing all purification
and size selection steps using magnetic beads, and reducing the
volume of some reactions (a complete protocol is available in
Protocol S1). These relatively minor alterations were sufficient to
lower the amount of starting material required by more than an
order of magnitude.
We sequenced a total of 24 mRNA samples on an Illumina
GAIIx Genome Analyzer. We aligned reads to the D. melanogaster
reference sequence (version 5.23) using Bowtie [18] and inferred
transcript levels using TopHat [19] and Cufflinks [20]. We
normalized expression levels between samples so that the total
inferred expression levels of autosomal transcripts were identical.
Statistics on the sequencing and mapping are reported in Table 1.
The single embryo mRNA-Seq method was highly reproducible
and has a wide dynamic range (Figure 1C). Transcript levels over
all genes from individuals of the same sex and stage had
correlation coefficients from 0.95–0.97 (Spearman’s rank correla-
tion); transcript levels from individuals of the same stage but
different sex were correlated to a similar degree. In contrast,
transcript levels from embryos of the same sex but different stage
had correlations ranging from 0.80–0.97.
Author Summary
Variation in gene dose can have profound effects on
animal development. Yet every generation, animals must
cope with differences in sex chromosome numbers.
Drosophila compensate for the difference in X chromo-
some dosage (two in females, one in males) with a
mechanism that allows for more transcription of the single
X chromosome in males. But this mechanism is not
established until over an hour after the embryo begins
transcription, during which time a number of important
events in development occur such as cellularization and
segmentation. Here we use an mRNA sequencing method
to characterize gene expression in individual female and
male embryos before the onset of the previously
characterized dosage compensation system. While we find
more transcripts from X chromosomal genes in females,
we also find many genes with equal transcript levels in
males and females. These results indicate that there is an
alternate mechanism to compensate for dosage acting
earlier in development, prior to the onset of the previously
characterized dosage compensation system.
Early Zygotic Dosage Compensation in Drosophila
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Polymorphism
In order to distinguish zygotic transcripts from those deposited
by the mother, we analyzed embryos produced by a cross of two
genetically distinct D. melanogaster lines: a w1 derived maternal line
(which contained the His2Av-RFP marker) and a Canton-S (CaS)
paternal line. We sequenced both lines to roughly 356 coverage
(see Table 2), mapped reads to the reference genome using maq
(maq.sourceforge.net), and identified 285,927 sites that differed
between the strains.
The vast majority of these differences were biallelic single-
nucleotide polymorphisms (SNPs) known from resequencing
projects to be polymorphic in the North American D. melanogaster
population (dpgp.org and DGRP). This is consistent with these
strains representing independent samples drawn from resident
populations in the United States. Although both lines have been in
laboratories for decades, we found that each harbored a significant
amount of residual polymorphism, especially CaS. We therefore
restricted our subsequent analyses to a set of 122,672 SNPs that
were fixed between strains.
Figure 1. A sex-specific timecourse of early-embryonic gene expression. (A) Transcription events during early embryogenesis. During the
first 8–9 mitotic cycles, almost all RNAs in the embryo are of maternal origin. Zygotic transcription begins at a low level at approximately cycle 10 and
becomes widespread by the middle of cycle 14. MSL-mediated dosage compensation begins late in or following cycle 14. (B) Embryos used for
mRNA-Seq. Individual embryos in the interphases of cycles 10 to 14 were selected by direct observation of mitosis in embryos containing histone
H2Av-RFP and computing nuclear density. Embryos at substages of cycle 14 were selected by observing the extent of progression through
cellularization (from proportion of membrane invagination) under light microscopy. Each embryo pictured here was placed into TRIzol reagent
immediately after these images were taken, DNA and RNA were extracted, and each sample was genotyped to determine the sex of the embryo.
(C) Approximately 100 ng total RNA was obtained from each embryo, and poly-A RNA was processed with an amplification-free protocol optimized
for small samples and sequenced on an Illumina GAIIx Genome Analyzer. Data (normalized reads per kb, RPKM) from independently processed
individuals of the same stage and same sex, and same stage but different sex were extremely similar, while individuals from different stages showed
larger numbers of differences.
doi:10.1371/journal.pbio.1000590.g001
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at least one fixed polymorphism, allowing us to assign RNA-Seq
reads spanning the polymorphism to either w1 or CaS (Figure 2A).
Since maternally deposited mRNAs should all be w1, any CaS
(paternal) reads must have been the result of zygotic transcription.
We were thus able to partition the overall expression of any
mRNA containing w1-CaS differences into its maternal and
zygotic component (Figure 2B). As expected, transcripts at cycle 10
were almost entirely maternal (Figure 2C). We observed
widespread zygotic transcription beginning in the middle of cycle
14, and by the end of cycle 14, we find a mix of persistent maternal
and zygotic transcripts, in varying proportions, depending on the
gene (Figure 2C).
We used the strain-specific time series to classify genes as
maternal, zygotic, or maternal and zygotic. Briefly, we clustered
(k-medians) the 5,226 genes with at least 10 reads spanning a
w1-CaS polymorphism into 20 groups based on similarity of their
inferred abundance of maternally and paternally derived tran-
scripts. We classified each cluster as maternal (only w1 mRNAs
detected with levels declining over time), zygotic (no mRNA at
cycle 10, with both w1 and CaS alleles detected over time), or
maternal and zygotic (only w1 mRNAs detected at cycle 10, with
CaS mRNAs appearing over time). Because of the absence of
paternal alleles for genes on the X chromosome in males, all
assignments were based on data from females only. We classified
genes lacking polymorphisms distinguishing the strains by
comparing their mRNA abundances from the eight female
samples to the average patterns from each of the previously
assigned groups. We assigned genes to the group with which their
expression pattern was best correlated (if the correlation coefficient
was greater than 0.8). Overall, 5,598 genes were classified as
maternal, 2,210 as zygotic, and 1,195 and maternal+zygotic (the
classification for each gene is listed in Dataset S1).
Profiles of Known Sex Determination and Dosage
Compensation Factors
Previous studies of sex determination and dosage compensation
have described the expression sex-specific patterns of expression in
a number of zygotically transcribed genes [2–5]. We examined the
expression patterns of these genes in our data to confirm that we
could effectively detect transcript differences in zygotically
transcribed genes between male and female embryos (Figure 3).
As expected, we observed that the numerator genes sisA, sisB (also
known as sc), and run are expressed at higher levels in females
(twice as high during cycles 11–12, Figure 3A), that early Sxl
expression is substantially higher in females (Figure 3B), and that
msl-2 is more abundant in males (Figure 3C). We did not observe
msl-2 transcript until the middle of cycle 14, consistent with earlier
studies demonstrating that MSL-mediated dosage compensation is
not established until after cellularization [9,10]. Collectively, these
data establish that we can reliably detect sex-specific differences in
expression where they exist.
X Chromosome Transcripts Are Female Biased But
Dosage Compensated
We next compared transcript levels of all 2,210 purely zygotic
genes in male and female embryos. Zygotically derived transcripts
from autosomal genes were observed at the same levels in females
and males (Figure 4A). In contrast, zygotically derived transcripts
from the X chromosome were consistently observed at higher
levels in females than in males (Figure 4A), with a female to male
ratio ranging from 1.0 to 2.0. The female to male ratio, and thus
the level of compensation, did not correlate with expression level
of the gene, or the position of the gene on the X chromosome.
The difference between the X chromosome and autosomes can
be seen clearly when total abundance of zygotically expressed
genes in males and females is compared between the X
chromosome and autosomes (Figure 4B). Autosomal transcript
levels were effectively identical in females and males at all time
points, and X chromosome transcript levels were higher in
females, yet not twice as high as in males. The ratio of transcript
levels of zygotic genes from the female to male X chromosomes
was approximately 1.45 over cycle 14 (mean of 1.5, median of 1.4,
Table 1. Sequencing statistics for single embryo mRNA-Seq
samples.
Sex Stage Reads Mapped Reads
Female 10 26,976,249 17,633,235
Female 11 27,988,411 17,105,590
Female 12 23,270,517 19,949,416
Female 13 24,615,381 20,388,812
Female 14A 21,322,865 16,349,815
Female 14A 18,590,935 16,036,761
Female 14B 18,545,524 15,121,569
Female 14B 19,244,061 17,316,317
Female 14C 20,902,589 17,346,048
Female 14C 18,459,025 16,647,754
Female 14D 23,128,318 19,327,028
Female 14D 17,750,907 15,848,586
Male 10 21,892,898 16,468,144
Male 11 18,250,299 12,796,916
Male 12 25,167,764 21,527,094
Male 13 23,830,913 18,156,530
Male 14A 22,696,841 18,738,955
Male 14A 19,301,209 17,208,613
Male 14B 23,409,763 16,417,656
Male 14B 18,501,195 16,617,463
Male 14C 22,471,826 18,740,316
Male 14C 17,617,204 15,340,670
Male 14D 20,536,683 16,674,908
Male 14D 18,532,116 15,888,989
doi:10.1371/journal.pbio.1000590.t001
Table 2. Strain-specific polymorphism statistics from genome
sequencing.
CantonS w1
Reads 65,907,258 63,716136
Mapped reads 57,375,508 55,489,784
Total mapped bases 5,794,926,308 5,604,468,184
Average coverage 34.36 33.26
Sites scored as polymorphic
with respect to reference
299,254 340,119
Sites polymorphic between strains 285,927
Fixed polymorphisms between strains 122,672
doi:10.1371/journal.pbio.1000590.t002
Early Zygotic Dosage Compensation in Drosophila
PLoS Biology | www.plosbiology.org 4 February 2011 | Volume 9 | Issue 2 | e1000590Early Zygotic Dosage Compensation in Drosophila
PLoS Biology | www.plosbiology.org 5 February 2011 | Volume 9 | Issue 2 | e1000590over all X chromosomal zygotic genes; for zygotic genes on
chromosome 2L, mean and median female to male ratios are 1.1
and 1.0, respectively).
We observed no difference in the levels of transcripts derived
from maternal or paternal chromosomes for either autosomes or
(in females) the X chromosome. Total expression of zygotic genes
from the paternal and maternal X chromosomes of females was
very similar (average Spearman’s rank correlation r=0.97 across
stages, some as high as r=0.999; Figure 4C). The total abundance
of zygotic genes from the single male X chromosome was
consistently higher (Figure 4C) than from either female X
chromosome—demonstrating that transcript abundance in the
early embryo transcription is subject to some form of dosage
compensation.
Figure 3. Transcription of sex determination and dosage compensation genes. The events in the sex determination pathway in our data
are consistent with previous studies. (A) Expression levels (normalized reads per kb, RPKM) for the X chromosome signal elements (XSEs; sisA, sisB, and
run) in female embryos reach twice the transcript abundance of male embryos (light blue line) near cycle 12. These factors activate Sxl expression (B)
in females, with significant female expression levels around cycle 13, the presence of which interferes with msl-2 expression (C), the male-specific
protein of the MSL-mediated dosage compensation, which is higher in males, starting mid-late cycle 14.
doi:10.1371/journal.pbio.1000590.g003
Figure 2. Polymorphisms distinguish maternal and zygotic expression. (A) Approximately 70% of genes expressed in the early embryo
contained fixed differences between the maternal (w1) and paternal (CantonS) lines, allowing us to partition the expression level for that gene at each
time point into those derived from the maternal and paternal chromosomes. (B) We classified genes based on temporal profiles of total mRNA and
(where available) mRNA derived from maternal and paternal chromosomes. Maternally deposited transcripts (,5,000) were expressed at high levels
that decay over time and come exclusively from the maternal chromosome. Zygotic transcripts (,2,000) were not present or were present at very low
levels at cycle 10, and transcript levels rose over time with equal contribution from maternal and paternal chromosomes. Approximately 800
transcripts are both maternally deposited and zygotically transcribed. (C) Left, the average proportion of zygotic reads per gene increases over time,
accelerating during mid cycle 14. Right, a histogram showing the proportion of zygotic reads over genes for an early and a late stage.
doi:10.1371/journal.pbio.1000590.g002
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the X Chromosome Are Nearly Completely Compensated
The sex ratio of transcript abundance for individual genes
varied somewhat over cycle 14, especially earlier in cycle 14 where
there are not many zygotic genes expressed. But across cycle 14,
the X chromosome consistently had an excess of genes with higher
transcript level in females (Figure 5A). Yet by the end of cycle 14,
there were few genes on the X chromosome that had a 2-fold
excess of transcript levels in females, and only approximately 30%
had more than a 1.75-fold enrichment. Approximately half of the
factors on the X chromosome had less than a 1.5-fold excess of
transcripts in females.
The expression patterns of the patterning genes whose presence
on the X chromosome motivated us to examine sex-specific
expression in the early embryo were particularly striking. For
example, giant, a textbook example of an important early
embryonic regulator on X for which differences in levels would
likely impact development [21], was almost perfectly dosage
compensated (Figure 5B), with equal transcript levels in males and
females corresponding to roughly 2-fold greater abundance of
mRNAs derived from the paternal X chromosome compared to
the X chromosomes in females. Other key X-linked developmental
regulators, including vnd, nullo, btd, tsg, and sog, were also present at
roughly equal levels in males and females.
As is often the case with dosage compensation mechanisms,
early zygotic dosage compensation is not universal, and several
genes showed no evidence of compensation at the transcript level
(Figure 5C). We assigned every zygotic gene with appreciable
expression levels (maximum normalized RPKM greater than 3.0)
a compensation score equal to the slope of the line fit (by least
squares) to the male and female transcript levels for that gene. The
distribution of these values for autosomal genes were centered
around 1.0 and rarely showed a greater than 1.5-fold difference
(Figure S1A). In contrast, 77 of the 85 zygotic genes on the X
chromosome were greater than 1.0 and 36 were greater than 1.5
(Figure S1A). These compensation scores are given in Dataset S1,
and plots of all zygotic genes on X sorted by this score are shown
in Figure S1B.
Discussion
Mechanisms of Early Zygotic Dosage Compensation
Our development of methods to examine sex-specific gene
expression in early D. melanogaster embryos was motivated by the
expectation that the earliest stages of zygotic transcription are not
dosage compensated and that resultant sex differences in the levels
of crucial patterning genes might have interesting phenotypic
consequences.
Instead, our genome-wide time course of transcript levels in
individual male and female embryos has revealed extensive dosage
compensation of X chromosomal transcript levels before the
canonical MSL-mediated dosage compensation process is thought
to be engaged. Crucially, mRNAs for key X-linked developmental
regulators, including gt, brk, btd, and sog, are present at essentially
identical levels in male and female embryos.
Although there is clearly early zygotic dosage compensation
(EZDC), our data speak only indirectly to the mechanism by
which it occurs. Assuming that, in an uncompensated system, we
would expect transcription to produce twice as many zygotically
derived copies of X chromosomal genes in females than in males,
the generally lower levels we observe in females must arise through
sex and X-chromosome-specific transcriptional or post-transcrip-
tional regulation.
The simplest explanation is that the MSL-based dosage
compensation system is active before and during cycle 14, leading
to hypertranscription of the male X. However, several imaging
studies of the male-specific localization of MSL proteins to, and
the subsequent acetylation of histones on, the male X chromosome
describe an at least 1 h lag between the onset of zygotic transcri-
ption and these hallmarks of MSL-mediated dosage compensation
[9,10]. While it is possible that these studies missed earlier low-
level or highly targeted MSL-binding and compensation that
escaped detection in the microscope, independent evidence exists
for MSL-independent dosage compensation in the early embryo
[22].
Through an analysis of larval cuticle patterns of male and
female embryos carrying various combinations of run hypomorphic
alleles, Gergen demonstrated that the X-linked gene run, which is
involved in both sex-determination and segmentation, is function-
ally dosage compensated [22]. Although run is expressed
throughout embryogenesis, the effects on larval cuticle patterns
these studies examined arise during the blastoderm stage and are
thus an example of EZDC. We also find that run is dosage
compensated during cycle 14. Gergen [22], and later Bernstein
and Cline [23], showed that dosage compensation of run is MSL
independent but requires the early female-specific form of Sxl.
Since SXL is an RNA-binding protein known to modulate
splicing and translation, it was proposed that dosage compensation
of run might result from direct SXL-mediated reduction of the
translation or stability of run in females [24]. Consistent with this
possibility, the 39UTR of run mRNA contains several matches to
the SXL consensus sequence [24]. However, a direct role for SXL
in run dosage compensation has not been confirmed.
The two best-characterized targets of SXL are msl-2 mRNA,
which it regulates by translational repression, and its own mRNA,
which it regulates by controlling how it is spliced. However, a total
of 88 genes (including run) have transcripts whose 39UTRs contain
three or more SXL target sites (AUUUUUUU or UUUUUUUU).
And of these an astonishing 76 are on the X chromosome. This
striking enrichment, originally noted by Kelley et al. [24] and
expanded by Cline [25], suggests a broad role for SXL in
specifically regulating the stability or activity of mRNAs derived
from the X chromosome. If the female-specific SXL is controlling
EZDC directly, it would have to do so by reducing the levels of X
chromosomal RNAs in females, as SXL is not present in males.
While such an activity has not been established for SXL, many
other RNA binding proteins are known to affect transcript levels
[26–29].
There is, however, imperfect agreement between predicted SXL
targets and genes we observe to be dosage compensated. Many
Figure 4. Zygotic transcription from the X chromosome is weakly female biased. (A) Female expression versus male expression for zygotic
genes (normalized reads per kb, per gene, log scale) over cycle 14, where most zygotic expression is detected. Autosomal gene expression was
centered around the purple line, where female and male transcript levels are even. For X chromosomal genes, transcript levels were distributed
between females and males having equal transcript abundance (solid line) and the female having twice the transcript level of the male (dotted line).
(B) Total expression levels (average normalized reads per gene) for zygotic genes in male and female embryos, on autosomes and the X chromosome.
Female expression on X is less than twice the level of male expression after cycle 12 (light blue line). (C) Zygotic transcripts from autosomal genes
were derived equally from the maternal or paternal chromosomes, while zygotic transcripts from the single X chromosome in males are present at
higher levels than those from either of the X chromosomes in females, demonstrating that the early embryo is dosage compensated.
doi:10.1371/journal.pbio.1000590.g004
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(Figure S1; gt, for example, is not a predicted target) and many
predicted SXL targets are not or are poorly dosage compensated
(Figure S1B). Furthermore, many predicted SXL targets on X are
maternally deposited, with no early zygotic transcription. These
genes are not expected to be affected by chromosomal dosage
differences. Indeed SXL acting to reduce the levels of these genes
in females would produce, rather than eliminate, dosage
differences. To resolve whether SXL plays a role in EZDC, we
are currently determining whether EZDC is present in Sxl
mutants, and whether SXL interacts specifically with EZDC
targets.
Figure 5. Early zygotic dosage compensation. Of the zygotic genes on the X chromosome, some had the same transcript levels in female and
male embryos, and some had an excess of transcripts in females relative to the male, indicating that some are transcriptionally dosage compensated
and some are not. (A) Proportion of genes that had higher transcript levels in males or females over cycle 14, comparing autosomes to the X
chromosome. The darker colors represent a stronger enrichment of female or male transcripts relative to the other sex. To reduce noise, ratios of
female to male expression were considered for genes where individuals of both sexes had at least 2 RPKM, little qualitative difference was observed in
results for higher thresholds (results not shown). (B) Key developmental regulators on the X chromosome were dosage compensated at the transcript
level. (C) Other zygotic factors on the X did not appear to be effectively dosage compensated, as there were large differences in expression between
male and female embryos.
doi:10.1371/journal.pbio.1000590.g005
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it is possible that dosage compensation arises from gene-specific
feedback. Many developmental regulators regulate their own
transcription [30,31], and such interactions could lead to full or
partial compensation of initially higher transcript levels in females
than males. However, this kind of feedback would also likely have
a significant time lag between the emergence of differences in
transcript levels and their compensation. There is evidence that
the early embryo is generally robust to environmental factors such
as temperature and some forms of genetic variation [32–35].
Systems conferring such robustness might also sense and
compensate for deviations arising from differences in X chromo-
somal dose.
Each of the models discussed above assume that, without
intervention, 2-fold differences in DNA dose inherently produce 2-
fold differences in transcription and transcript abundance, which
need, at least for some subset of genes, to be compensated.
However, this is not necessarily the case. Studies on autosomal
regions with altered dosage in Drosophila suggest an average 1.3–
1.5-fold increase in transcript level per copy [36–38]. Dosage
compensation of the X chromosome in Drosophila results in a ,2-
fold increase in transcription in males, relative to the autosomes
[36–38]. A recent study [39] estimates that the MSL-complex has
a 1.35-fold effect on expression of the X chromosome in males,
and suggests that X chromosome dosage compensation could
simply be the interaction of this 1.356 effect with the baseline
1.56 dosage effect. However, the effects of these altered gene
dosages in these experiments, which measure precise differences in
expression, are unknown. It is unclear whether these dosage
differences are comparable to the wild-type differences in X
chromosome dosage, and how to interpret the quantitative effects
as characterized. Regardless of what the baseline threshold for
compensated versus uncompensated transcription is with a 2-fold
dosage difference, we see many factors on the X chromosome with
no difference in transcription rates in males and females.
Additionally, the expectations of the interactions of gene dosage
and expression may not be the same in the unique transcription
environment of the early embryo. A recent study by Lu et al. [40]
compared gene expression during early development in diploid
and haploid embryos and found that transcript levels for a large
class of zygotically transcribed genes (those whose transcription is
dependent on developmental time, rather than nucleocytoplasmic
ratio) were dosage independent.
To explain this observation, Lu et al. [40] proposed a model in
which transcription is limited by an unknown, maternally
deposited, factor. Since both haploid and diploid embryos would
have the same amount of this limiting factor, and since individual
genes would be present in the same proportion to each other, rates
of transcription across the genome would be the same. However,
the limiting factor hypothesis cannot explain X chromosomal
dosage compensation, as halving the dosage of X chromosomal
genes relative to autosomal genes in males would lower the relative
rate of transcription of X chromosomal genes (compared to
autosomes) at any concentration of the limiting factor.
There is a related alternative to the limiting factor hypothesis
that could explain both dosage compensation and insensitivity to
ploidy, concerning the accessibility of DNA templates. Homolo-
gous chromosomes are known to be paired throughout Drosophila
development [41,42], and imaging of nascent transcripts in the
early embryo consistently shows the close proximity of transcribed
alleles. Given that transcription involves localization to specific
subnuclear regions and attachment to large protein machines, it
seems possible that the transcription of one allele could make it
difficult or even impossible to transcribe the other allele. If such an
effect occurred, then the embryo will be inherently dosage
compensated. If only one copy of a gene is present (for the whole
genome in haploid embryos or the X chromosome in males), it is
transcribed at whatever rate the various regulatory systems active
dictate. If two copies of the same gene are present (as in diploids
and females), the gene would be expressed at the haploid level,
with expression divided across the two alleles.
While no such mechanism has been described, the rapid mitotic
cycles of early development place constraints on transcription [43]
and might make the early embryo particularly sensitive to such
effects. It has also long been observed in Diptera, that homologous
chromosomes pair during mitosis, as well as meiosis [41,42].
Expression can be affected by the pairing of homologs, through
phenomena such as transvection [44–46], the control of genes by
regulatory interactions with their homologs in trans. Pairing of
some homologous loci is observed as early as cycle 13 and
increases through cycle 14 [47–50], precisely at the times EZDC is
observed. As pairing of homologous loci also seems to occur at
particular sites rather than ‘‘zippering’’ along a chromosome [48],
this could also explain why some sites seem compensated and
others do not.
Yet, contrary to this, near synchronous appearance of two
adjacent dots in many nuclei in RNA in situ hybridization of
intronic probes from autosomal genes demonstrates that paired
alleles can both be transcribed at roughly the same time [4,51,52].
But it leaves open the possibility that the transcription of one allele
could affect the rate at which the other is transcribed.
Whatever the mechanism turns out to be, our data provide an
unprecedented window on the temporal dynamics of transcript
levels in male and female embryos, and establish that some
mechanism exists that ensures that differences in sex chromosome
dose do not translate into differences in mRNA abundance during
a crucial period of D. melanogaster development.
Beyond Dosage Compensation
While our focus here was on dosage compensation, our data
represent a significant advance over earlier methods to monitor
gene expression in the early D. melanogaster embryo by providing
higher temporal resolution and precision, sex specificity, and
unambiguous discrimination of maternally deposited and zygot-
ically transcribed mRNAs. Our use of individual embryos also
provides a window onto embryo-to-embryo variability in tran-
script levels, which we found to be surprisingly low.
We hope that our data, which are being made available in full
here, will help address a number of other open questions about
transcription during early D. melanogaster embryogenesis. And we
suspect that the methods we developed for analyzing mRNA from
individual Drosophila embryos and other aspects of our experimen-
tal design will be of interest to researchers interested in the analysis
of small RNA samples. Although our experiments worked
exceptionally well, in carrying them out, we made several
observations that should be of interest and use to other
investigators.
First, we routinely obtained at least 10 times more material from
processing the RNA from a single embryo than was needed for a
single Illumina sequencing lane. This suggests that the RNA
content of even smaller samples could be routinely analyzed
without RNA amplification. Second, for a variety of reasons,
mostly involving cost, we carried out 36 base pair single-end
sequencing runs. In retrospect, we would have been able to assign
many more reads to distinct parental chromosomes, and perhaps
detected sex-specific splicing, had we carried out longer, paired-
end runs. Finally, analyzing embryos from a cross of divergent
strains was very useful. But we were surprised at how polymorphic
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suspect this is a general phenomenon, and suggest that all
researchers doing experiments that require highly inbred lines
specifically inbreed the lines they are using and resequence them
to characterize residual polymorphism prior to use.
Materials and Methods
Fly Line and Imaging
Flies were raised on standard fly media in uncrowded
conditions, at room temperature. 2–3-d-old virgin females of the
His2Av-mRFP1 III.1 line (Bloomington stock center, stock
no. 23650) [53] were crossed to Canton-S males, and eggs were
collected from many 3–6-d-old females, thus minimizing chances
that multiple embryos sampled would come from the same
mother. After collection, eggs were dechorionated, placed on a
slide in halocarbon oil, and visualized using a Nikon Eclipse 80i
microscope, with a Nikon DS-UI camera, and the NIS Elements F
2.20 software. Embryos were photographed both for fluorescence
with an RFP filter to visualize nuclei and under white light with a
DIC filter to visualize the extent of cellularization in mitotic cycle
14 embryos (Figure 1B). Embryos were then moved from the slide,
cleaned from excess oil, and placed in a drop of TRIzol reagent
(Invitrogen) within a minute or less of imaging. Embryos are then
ruptured with a needle, allowed to dissolve, and moved to a tube
with more TRIzol reagent, which was then frozen at 280uC. For
determining the age (mitotic cycle) of each embryo, images of
nuclei were analyzed in ImageJ (1.42q), where nuclear numbers
were counted in a 2006200 pixel box, to confirm the nuclear
division cycle of each embryo. For those embryos within mitotic
cycle 14, the DIC photographs showing the extent of membrane
invagination were used to create subclasses within cycle 14
(Figure 1B).
RNA Extraction, Genotyping, and Sequencing Library
Preparation
RNA and DNA extraction from single embryos was done with
TRIzol (Invitrogen) reagent according to the manufacturer’s
protocol, except with a higher volume of reagent relative to the
amount of material (i.e. starting with 1 mL of TRIzol despite
expecting very small amounts of DNA and RNA). Extracted DNA
was amplified using the Illustra GenomiPhi V2 DNA Amplifica-
tion Kit (GE Healthcare), and embryos were sexed by detecting
the presence of a Y chromosome, using PCR with primers to a
region of the male fertility factor kl5 on the Y chromosome
(forward primer GCTGCCGAGCGACAGAAAATAATGACT,
reverse primer CAACGATCTGTGAGTGGCGTGATTACA),
and a region on chromosome 2R (forward primer AAAAGG-
TACCCGCAATATAACCCAATAATTT, reverse primer GTC-
CCAGTTACGGTTCGGGTTCCATTGT) as a control.
Total RNA was made into libraries for sequencing using the
mRNA-Seq Sample Preparation Kit from Illumina, following an
altered mRNA-Seq library making protocol developed at Illumina
(see complete protocol in Protocol S1). Libraries were quantified
using the Kapa Library Quantification Kit for the Illumina
Genome Analyzer platform (Kapa Biosystems), on a Roche
LC480 RT-PCR machine, according to the manufacturer’s
instructions.
RNA Sequencing
An alternate flow cell loading protocol for small concentration
sequencing libraries was developed for this study and used here,
despite the libraries created largely being concentrated enough not
to necessitate use of this method (see Protocol S2). For each
sample, 40 pM of library (relative to final concentration loaded on
to flow cell) was diluted in 4 uL, and 1 uL of 0.5 M sodium
hydroxide was added. Samples were left 5 min to denature, then
placed on ice, and 1 uL 0.5 M hydrochloric acid added, then
diluted to final loading concentration (of at least 20 uL) with
Illumina hybridization buffer. To load sample on an Illumina flow
cell, an air gap was created, the entire sample drawn into the
hybridization manifold, an air gap left after the sample, and
hybridization buffer used to push the sample until it is centered on
the flow cell (see complete protocol in Protocol S2). The rest of the
cluster generation and sequencing were according to normal
protocols, for 40 cycle sequencing with the Illumina Genome
Analyzer (GAIIx).
Genome Sequencing
We prepared genomic DNA from 10 females from our CaS and
w1 stocks. We prepared Illumina paired-end sequencing libraries
using standard protocols and sequenced two 101 bp paired-end
lanes for each strain on an Illumina GAIIx Genome Analyzer.
Data, SNP Detection, Mapping, Calling Maternal and
Zygotic
Reads from each RNA-Seq sample were mapped to the
reference D. melanogaster genome (FlyBase release 5.27 [54,55])
using Bowtie [18] and TopHat [19], and transcript abundances for
annotated RNAs were called by Cufflinks [20]. Data from each
sample were normalized so that the total expression (reads per kb
of sequence, per million mapped reads; RPKM) of autosomal
genes was constant. Genomic reads were mapped to the D.
melanogaster genome (FlyBase release 5.27) using maq (maq.source-
forge.net). We found that consensus base and SNP calling
algorithm was adversely affected by the high level of polymor-
phism, especially in the CaS sample, so we exported the base-by-
base pileup from maq and developed our own SNP calling
algorithm. We designated a position as a CaS-w1 SNP if there were
at least 13 reads covering the base in each strain, if the frequency
of the most common base in each strain was at least 95%, and if
these most frequent bases differed. We also generated a w1-CaS
consensus sequence consisting of the reference D. melanogaster
bases, except where the sequences of the two strains agreed but
differed from the reference. We identified all RNA reads expected
to differ between the strains, counted their frequencies in each
sample, and partitioned the RPKM values for individual genes
into their w1 and CaS components in proportion to the fraction of
reads in that sample that mapped to the maternal or paternal
chromosome. Upon examination of the data, we became
concerned that absence of reads from the paternal X chromosome
and the low levels of Sxl in embryo F13 arose from a genotyping
error. So for graphs showing single genes, we use an average
between F12 and F14A for this time point.
We used the strain-specific time series to classify genes as
maternal, zygotic, or maternal and zygotic. We clustered
(k-medians) the 5,226 genes with at least 10 reads spanning a
w1-CaS polymorphism into 20 groups based on similarity of their
inferred abundance of maternally and paternally derived tran-
scripts using Cluster 3.0 [56]. We classified each cluster as
maternal (only w1 mRNAs detected with levels declining over
time), zygotic (no mRNA at cycle 10, with both w1 and CaS alleles
detected over time), or maternal and zygotic (only w1 mRNAs
detected at cycle 10, with CaS mRNAs appearing over time).
Because of the absence of paternal alleles for genes on the X
chromosome, all assignments were based on data from females
only. We classified genes lacking polymorphisms distinguishing the
strains by comparing their mRNA abundances from the eight
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assigned groups. We assigned genes to the group with which their
expression pattern was best correlated (if the correlation coefficient
was greater than 0.8).
Data Availability
All reads have been deposited in the NCBI GEO under the
accession number GSE25180 and will be made available at the
time of publication. The processed data are available at the journal
website (Dataset S1) and at eisenlab.org/dosage.
Supporting Information
Figure S1 Extent of dosage compensation for zygotic genes on
the X chromosome. Each gene was assigned a female to male
(F:M) ratio score equal to the slope of the line fit (by least squares)
to the male and female transcript levels for that gene over all time
points. (A) Proportion of genes with F:M ratios between 1.0 (equal
expression in males and females) and 2.0 (twice expression in
females). (B) Transcript abundance time series for zygotic genes on
the X chromosome, in female and male embryos, over all time
points. Genes sorted by F:M ratio.
Found at: doi:10.1371/journal.pbio.1000590.s001 (2.11 MB PDF)
Dataset S1 Normalized read counts per gene for each individual
embryo.
Found at: doi:10.1371/journal.pbio.1000590.s002 (2.89 MB
TXT)
Protocol S1 Small sample RNA-Seq protocol.
Found at: doi:10.1371/journal.pbio.1000590.s003 (0.14 MB PDF)
Protocol S2 Low concentration sequencing library loading
protocol.
Found at: doi:10.1371/journal.pbio.1000590.s004 (0.08 MB PDF)
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